HIV-infection/Aids Clinical Trial
Official title:
HIV Risk Reduction Among Young Incarcerated Females
Verified date | October 2011 |
Source | Mississippi State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
This project assesses the efficacy of an HIV prevention program with adolescent females incarcerated in the Mississippi training school for girls. Participants in both the health education control group and the HIV prevention group will increase health knowledge as a result of their participation in the health classes while incarcerated. However, participants in the HIV prevention group will increase their condom application, assertiveness, and communication skills relative to girls in the health education only group. In addition, after release from the training school, participants in the HIV prevention group will report lower sexual risk behaviors and will have lower rates of infection with chlamydia and gonorrhea during the 12-month follow-up period than participants in the health education only group.
Status | Completed |
Enrollment | 333 |
Est. completion date | December 2009 |
Est. primary completion date | December 2008 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 13 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Female, ages 13 to 17 years, committed to Columbia Training School, who provide written informed assent. Exclusion Criteria: - Acute or chronic physically illness that would preclude participation as determined by facility physician; placement in maximum security unit; study participation during a prior commitment |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Columbia Training School | Columbia | Mississippi |
Lead Sponsor | Collaborator |
---|---|
Mississippi State University | National Institute on Drug Abuse (NIDA) |
United States,
Robertson AA, St Lawrence J, Morse DT, Baird-Thomas C, Liew H, Gresham K. The Healthy Teen Girls project: comparison of health education and STD risk reduction intervention for incarcerated adolescent females. Health Educ Behav. 2011 Jun;38(3):241-50. doi — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | number of partners and frequency of sexual risk behaviors | Sexual behaviors included condom use in the 3 months prior to each assessment. Unprotected sex occasions (USOs) was calculated by subtracting the number of condom-protected vaginal and anal intercourse occasions from the total number of vaginal and anal intercourse occasions. Sex under the influence is the number of times participant reported sexual intercourse after drinking alcohol or using another drug. Safer sex was categorized as sexually abstinent or consistent condom use. | at 6 & 12 months | No |
Primary | infection with chlamydia or gonorrhea | one year | No | |
Secondary | reproductive health knowledge | Assessed as the number of correct answers to 37 treu/false and multiple choice questions | pre and post-intervention | No |
Secondary | condom application skill | Measured by observing participants apply and remove a condom from a penile model and a 10-item checklist | pre and post-intervention | No |
Secondary | Communication skills | Assessed during three role-play vignettes that place the respondent in a high-risk sexual or drug use situation and asked them to respond to a series of three escalating prompts as though the situation was actually happening. | pre and post-intervention | No |
Secondary | Perceived barriers to condom use | assessed using the Condom Barrier Scale (St. Lawrence, Chapdeline, et al., 1999) | at baseline, 6 and 12 month follow-up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03403569 -
Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection
|
Phase 3 | |
Completed |
NCT02433743 -
Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA
|
N/A | |
Recruiting |
NCT02753049 -
Adherence Connection for Counseling, Education, and Support
|
N/A | |
Completed |
NCT01360762 -
Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
|
Phase 3 | |
Recruiting |
NCT03147859 -
Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection
|
Phase 2 | |
Recruiting |
NCT04297488 -
Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection
|
N/A | |
Completed |
NCT01827540 -
Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
|
Phase 1 | |
Completed |
NCT01475890 -
Vitamin D Supplementation in HIV
|
Phase 2/Phase 3 | |
Recruiting |
NCT05947539 -
Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention
|
N/A | |
Withdrawn |
NCT01442428 -
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
|
Phase 2/Phase 3 | |
Completed |
NCT02496793 -
Community-Based Peer Facilitator Intervention (Zimbabwe)
|
N/A | |
Completed |
NCT03069235 -
Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program
|
N/A | |
Completed |
NCT03794648 -
The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication
|
N/A | |
Withdrawn |
NCT04183738 -
Inflammation and Co-Infections in D²EFT
|
Phase 4 | |
Enrolling by invitation |
NCT03919695 -
Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda
|
N/A | |
Recruiting |
NCT04215926 -
NAFLD in HIV-infected Patients
|
||
Completed |
NCT01406626 -
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
|
N/A | |
Completed |
NCT04371835 -
COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings
|
||
Completed |
NCT01140633 -
Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda
|
N/A | |
Enrolling by invitation |
NCT04373551 -
WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)
|
N/A |